Corcept Therapeutics Incorporated Profile Avatar - Palmy Investing

Corcept Therapeutics Incorporated

Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral m…

Biotechnology
US, Menlo Park [HQ]
Strategy & Leadership

Mergers & Acquisitions Beta

M&A Deals · Breakdown

Corcept Therapeutics Incorporated has no acquisition track records yet.

M&A Deals · History

Corcept Therapeutics Incorporated has no acquisition track records yet.

End of CORT's Analysis
CIK: 1088856 CUSIP: 218352102 ISIN: US2183521028 LEI: - UEI: -
Secondary Listings
CORT has no secondary listings inside our databases.